Edward M Liddy is Director of AbbVie Inc.. Currently has a direct ownership of 26,683 shares of ABBV, which is worth approximately $5.23 Million. The most recent transaction as insider was on May 07, 2021, when has been sold 1,681 shares (Common Stock, $0.01 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.7K
0% 3M change
0% 12M change
Total Value Held $5.23 Million

EDWARD M LIDDY Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 07 2021
BUY
Grant, award, or other acquisition
-
1,681 Added 5.93%
26,683 Common Stock, $0.01 pa...
May 08 2020
BUY
Grant, award, or other acquisition
-
2,333 Added 8.53%
25,002 Common Stock, $0.01 pa...
May 03 2019
BUY
Grant, award, or other acquisition
-
2,419 Added 9.64%
22,669 Common Stock, $0.01 pa...
May 04 2018
BUY
Grant, award, or other acquisition
-
1,899 Added 8.57%
20,250 Common Stock, $0.01 pa...
May 05 2017
BUY
Grant, award, or other acquisition
-
2,770 Added 13.11%
18,351 Common Stock, $0.01 pa...
May 06 2016
BUY
Grant, award, or other acquisition
-
2,974 Added 16.03%
15,581 Common Stock, $0.01 pa...
May 08 2015
BUY
Grant, award, or other acquisition
-
2,187 Added 14.78%
12,607 Common Stock, $0.01 pa...
May 09 2014
BUY
Grant, award, or other acquisition
-
2,764 Added 20.96%
10,420 Common Stock, $0.01 pa...
May 06 2013
BUY
Grant, award, or other acquisition
-
2,535 Added 24.87%
7,656 Common Stock, $0.01 pa...

Also insider at

ABT
ABBOTT LABORATORIES Healthcare
EML

Edward M Liddy

Director
North Chicago, IL

Track Institutional and Insider Activities on ABBV

Follow AbbVie Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABBV shares.

Notify only if

Insider Trading

Get notified when an Abb Vie Inc. insider buys or sells ABBV shares.

Notify only if

News

Receive news related to AbbVie Inc.

Track Activities on ABBV